| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |